Compare moats
Up to three covered companies, band by band. Every call is a curated editorial judgment, never a disclosed figure — and every band carries its cited basis.
| RELX plc | GitLab | Camtek | |
|---|---|---|---|
| Moat rating | wide Independent sources support entrenched positions in RELX's two content businesses. In legal research, a Stanford-led study of legal AI tools (arXiv 2405.20362v1, 2024-05-30, https://arxiv.org/html/2405.20362v1) says Thomson Reuters and LexisNexis "have historically enjoyed a virtual duopoly over the legal research market" (citing a 2006 article for that point) and "continue to be two of the largest incumbents now selling legal AI products". In scientific publishing, Larivière, Haustein and Mongeon in PLOS ONE (2015-06-10, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0127502) found Reed-Elsevier published 24.1% of natural and medical sciences papers in 2013, the largest share, and that its Scientific, Technical & Medical division's profit margin "steadily increased from 30.6% to 38.9% between 2006 and 2013." RELX's 2025 Annual Report (published 2026-02-19) shows the economics continuing: revenue of £9,590m, adjusted operating profit of £3,342m and an adjusted operating margin of 34.8% against 33.9% in 2024, with 54% of revenue from subscriptions. The limits are in the same report. Its principal risks say "We operate in highly competitive and dynamic markets" that change with "technological innovations, such as the use of artificial intelligence" and "the entrance of new competitors". Exhibitions holds "a global market share of less than 10%" in "a fragmented industry", and the Chair noted "share price volatility across a number of sectors, including software and data services." Long-held positions in legal research and scientific publishing, with margins that have kept rising, support a wide rating. The main threat is AI-native competition, which has not yet slowed reported growth. | narrow The FY2026 10-K (year ended 2026-01-31) shows real expansion inside the installed base: 118% Dollar-Based Net Retention, Base Customers up to 10,682 from 9,893, customers above $100,000 of ARR up to 1,456 from 1,229, and $1.0 million ARR customers "to 155 from 123, an increase of 26%". But the filing concedes "limited barriers to entry" and names "Microsoft Corporation, which owns GitHub" as principal competitor. Retention decelerates (130% FY2024, 123% FY2025, 118% FY2026), and since DBNR is reported "on a threshold basis of 130%," the FY2024 figure is a cap and the slide is steeper than it looks. Narrow, not wide: expansion must be re-won against a bundled hyperscaler. | narrow Camtek holds a strong position in the AI-driven niche of advanced-packaging inspection, but the evidence for a durable lead is mostly its own. Its August 2026 investor presentation (https://cdn.camtek.com/wp-content/uploads/IR-Presentation_Aug26.pdf) calls it the 'Market leader in Metrology and Inspection for Advanced Packaging' and says 'Most of the wafers used for HPC are measured and inspected on Camtek tools'. On the Q3 2025 call (2025-11-10) the COO said 'We are tool of record for all the 3D metrology for HBM4 at all the HBM manufacturers'. The one independent ranking found, The Information Network's post on SemiWiki, also calls Camtek 'the leader in inspection and metrology in advanced packaging', but it dates from February 2021. Margins are solid rather than exceptional: GAAP gross margin was 50.5% in 2025 and 48.9% in 2024 (Q4 2025 release), after 46.80% in 2023 (August 2026 presentation). The 2025 20-F (filed 2026-03-19) warns of 'significant global market participants, some with greater resources than us', and of local competitors that 'target the low-end market and may offer products at lower prices'. Onto Innovation's 10-K names KLA and Camtek as its principal advanced-packaging inspection competitors. China was the largest region at 243,935 of 496,072 (US$ thousands) of 2025 revenue. A real but contestable position, so narrow. |
| Moat type | intangibles ip RELX says its advantage is proprietary content and data. The 2025 Annual Report says it builds products by combining "our unique content and comprehensive data sets with advanced technologies", describes Lexis+ AI as "built and trained on one of the world's largest repositories of accurate and exclusive legal content", and cites more than 3,000 Elsevier journals including the Cell Press and The Lancet families. On the H1 2026 results call (2026-07-23, https://www.relx.com/~/media/Files/R/RELX-Group/documents/investors/transcripts/first-half-results-2026-transcript.pdf) the CEO said Risk grows by "leveraging our unique contributory and proprietary datasets, with over 90% of revenue coming from machine-to-machine interactions." Independent support comes from PLOS ONE (2015), which says libraries face a publisher oligopoly in which "each product represents a unique value and cannot be replaced". According to the annual report, in June 2025 LexisNexis agreed a strategic alliance with Harvey, an AI platform for legal and professional services, under which LexisNexis "will integrate its Lexis+ AI capabilities (powered by LexisNexis content) within the Harvey platform". Switching costs add to this: legal products are sold "on a paid subscription basis, with subscriptions often under multi-year contracts." | switching costs Stickiness comes from platform embedding, not IP. The 10-K rests differentiation on "our single platform with a unified data model," on "Consolidation of multiple tools into a single platform," and on deployment inside the customer's own perimeter for regulated buyers. Replacement means re-integrating a toolchain and re-certifying compliance. IP is the wrong label: only "16 issued patents and 25 pending patent applications," plus open-source licenses granting "broad permissions to use, copy, modify, and redistribute." The no-lock-in claim is the filing's own characterisation, footnoted to a Forrester study "commissioned by GitLab." | intangibles ip The 20-F attributes the advantage to engineering capability: 'We believe that a significant part of our competitive advantage derives from our R&D innovative capabilities which enable us to adapt our technologies to evolving market needs and customers' requirements.' Its systems 'incorporate proprietary advanced image processing software and algorithms, as well as advanced electro-optics and precision mechanics', and it relies on 'patents, copyrights, trade secrets, trademarks, confidentiality and non-disclosure agreements'. The new platforms carry that forward: the 20-F says the Hawk detects '150 nanometer defects size' and measures '500 million micro bumps at pitches less than 12 micron'. Tool-of-record status adds switching friction, per the COO's HBM4 remark on the Q3 2025 call. But the 20-F also says 'it may be possible for a third party, including a competitor, to copy or otherwise obtain and use our products or technologies without authorization or to develop similar technologies independently'. |
| Leadership | co leader RELX's own 2025 Annual Report ranks its businesses as Risk "Key verticals #1", STM "Global #1", Legal "US #2" and "Outside US #1 or #2", and Exhibitions "Global #2". Independent sources, both dated, support two of these. PLOS ONE (2015) puts Reed-Elsevier first in natural and medical sciences publishing with 24.1% of 2013 papers, ahead of Springer (11.9%) and Wiley-Blackwell (11.3%). The Stanford study (2024-05-30) describes legal research as a historical duopoly of Thomson Reuters and LexisNexis, and found that "Lexis+ AI is the highest-performing system we test, answering 65% of our queries accurately." The publishing data is from 2013, Legal is second in the U.S. by RELX's own account, and the Risk and Exhibitions ranks are the company's own claims. That supports co-leader, not clear leader. | fast follower The 10-K positions GitLab against a leader rather than as one: "Our principal competitor is Microsoft Corporation, which owns GitHub." Competition reads from the challenger side, differentiating "from GitHub through flexible deployment options that work within enterprise security and compliance requirements, LLM neutrality with self-hosted gateway support" and an open core model. On AI it follows: Duo Agent Platform went "Generally available in January 2026," the last month of the fiscal year. What keeps it a follower rather than behind is cadence, "a new version of our software every month for 172 months in a row," plus a regulated-deployment franchise a SaaS-first rival does not cover. | co leader Camtek calls itself the 'Market leader in Metrology and Inspection for Advanced Packaging', and on the Q3 2025 call (https://finance.yahoo.com/markets/stocks/articles/camtek-camt-q3-2025-earnings-165201423.html) the CEO said its tools 'are the tools of reference for 3D metrology steps for HBM4 at all the HBM players'. The only independent support found is older: The Information Network's 2021 SemiWiki post (https://semiwiki.com/forum/threads/kla-still-top-of-semiconductor-metrology-inspection-but-smaller-competitors-gain-share-in-2020.13803/latest) calls Camtek 'the leader in inspection and metrology in advanced packaging', in a market where 'KLA is the dominant metrology/inspection market leader with a share of more than 50% in 2020' overall. KLA and Onto Innovation both compete for the same advanced-packaging inspection steps, per Onto's 10-K, and Nova's 20-F says its Sentronics acquisition puts it in 'direct competition' with Camtek. With no current independent share data, the band is held at co_leader. |
| Pricing power | moderate The 2025 Annual Report says RELX products "often account for less than 1% of our customers' total cost base but can have a significant and positive impact on the economics of the remaining 99%", and reports a group adjusted operating margin of 34.8% in 2025 against 33.9% in 2024. On the H1 2026 call the CFO reported a margin of 35.5%. He attributed the gains to cost discipline: "we focus on ensuring that cost growth remains below revenue growth in all of our businesses." The CEO said that "roughly 3/4 of the renewal value is coming from the Lexis+ with Protégé package", which means renewals are moving customers onto the higher-value AI platform. Independent evidence on Elsevier is older. PLOS ONE (2015) says libraries "have to manage with less as prices increase" and that, because of the oligopoly, they are "more or less helpless". It also found the STM division's profit margin never fell below 30% over the 1991-2013 period it studied. RELX does not disclose list-price increases. Most of the evidence is margin-based. The margins are high and rising, but management credits the gains to keeping cost growth below revenue growth, and the only independent evidence of price increases is from 2015. That supports moderate, not strong, pricing power. | moderate FY2026 gross margin was 87% against 89%, with cost of revenue up $35.6 million "primarily due to an increase of $18.4 million in third party hosting costs for SaaS and cloud usage," and management expects SaaS and Duo mix to bring costs that "may adversely impact our gross margins." Strain is explicit: GitLab "may be required to reduce our prices," competitors "may offer their products and services at a lower price or for free," and it "implemented user limits on our free SaaS product." Power retained: Premium lists at $29 per user/month billed annually, and seats bundle $12 and $24 of GitLab Credits. But "A majority of our subscriptions are on a one-year period." | moderate GAAP gross margin was 47.00% in 2020, 50.90% in 2021, 49.80% in 2022, 46.80% in 2023 and 48.90% in 2024 (August 2026 presentation, https://cdn.camtek.com/wp-content/uploads/IR-Presentation_Aug26.pdf), then 50.5% in 2025 (Q4 2025 release, https://www.camtek.com/news-and-events/camtek-announces-record-results-for-the-fourth-quarter-full-year-2025/) and 50.1% in Q2 2026. On the Q3 2025 call the CFO said gross margin 'should gradually improve' as the Hawk and the Gen 5, 'which have higher gross margin', ship. The same presentation's target model sets a 54-55% gross-margin target at $750 million of revenue. The 20-F warns that competition 'could result in lower prices for our products and a corresponding reduction in our gross margin'. |
| Summary | RELX sells information-based analytics and decision tools in four business areas. In 2025, per its Annual Report, Risk (LexisNexis Risk Solutions) had revenue of £3,485m and adjusted operating profit of £1,305m; Scientific, Technical & Medical (Elsevier) £2,714m and £1,035m; Legal (LexisNexis Legal & Professional) £1,806m and £415m; and Exhibitions (RX) £1,186m and £410m. The moat rests on content and data that are hard to replicate. A Stanford study describes a historical Westlaw-LexisNexis "virtual duopoly" in legal research. A PLOS ONE study found Reed-Elsevier the largest publisher of natural and medical sciences papers in 2013, and RELX reports that Elsevier articles accounted for "over 18% of global research output and 29% of citations" in its latest comparison. Risk is built on contributory databases such as the C.L.U.E. claims history database, which "collects and reports up to seven years of US personal automobile, property claims and small business information". The products are cheap relative to what customers spend: RELX says they "often account for less than 1% of our customers' total cost base". Group adjusted operating margin rose to 34.8% in 2025 and to 35.5% in the first half of 2026. AI is the main test of the moat. RELX is turning it into upsell: about 90% of Legal new-sales value now comes from the AI-enabled Lexis+ with Protégé platform, and Legal underlying revenue growth reached 10% in H1 2026. On the same call, an analyst cited AI-native legal players Harvey and Legora with combined annual recurring revenue above $400 million, and the CEO said RELX is "not going to be the leader" in the much larger legal workflow software market. RELX names the shift to open access as a principal risk for Elsevier. On the 2026 call, an analyst raised a U.S. OMB proposal to make journal subscription costs and article processing charges unallowable expenses on federal research awards. | GitLab sells a single-platform DevSecOps toolchain defended by workflow lock-in rather than intellectual property: a unified data model plus deployment flexibility, including single-tenant "Dedicated for Government with FedRAMP compliance," makes it hard to remove where data residency is contractual. The installed base expands: 118% Dollar-Based Net Retention, 10,682 Base Customers, 1,456 above $100,000 of ARR, 155 above $1.0 million (up 26%), over 70% of ARR from public sector and enterprise. The filing supplies the counterweight: "limited barriers to entry," Microsoft/GitHub as principal competitor, 16 issued patents. Retention (130 to 123 to 118, the 130 a cap), gross margin (89% to 87%) and a January 2026 AI launch point to compression at the commodity end. No source measures market share, so every share band is "unknown". | Camtek, based in Israel, makes optical inspection and metrology systems that check wafers from the back end of the front-end line through bump formation to post-dicing. Its current platforms are the Eagle family (including the Eagle G5, launched September 2024), the Hawk (launched February 2025 for chiplets, HBM and hybrid bonding), FRT's MicroProf metrology tools (acquired November 2023) and the Golden Eagle for panel-level packaging. The August 2026 presentation says advanced packaging is about 75% of revenue, HPC and AI about 55% and non-AI advanced packaging about 20%. The remaining 25% covers general 2D, photonics, power devices, CIS and front-end, and Eagle gen5 and Hawk 'are expected to account for 50% of 2026 revenue'. 2025 revenue was a record $496.1 million, up 16%, and Q2 2026 a record $133.2 million. The CEO said orders since the start of 2026 total 'more than $600 million', with deliveries 'throughout the remainder of 2026 and into 2027'. The 20-F says Camtek's systems 'are being used by the largest CIS manufacturers' and that it has 'widened its presence' in front-end back-end-of-line inspection. The exposures are China (the largest region in 2025), customer concentration (three customers took 15%, 10% and 10% of 2024 revenue, one took 11% in 2025), better-resourced rivals and low-priced local competitors, and a past patent claim by 'one of our competitors in the field of semiconductor wafer inspection equipment'. |
| Chain position | An AI-application-layer user of frontier models: on the H1 2026 call the CEO said RELX takes AI tools "from the sort of frontier lab companies" and runs them inside its own products on verified content. The 2025 Annual Report says LexisNexis will integrate Lexis+ AI capabilities, powered by LexisNexis content, within the Harvey platform. | GitLab sits at the software-tooling layer, not compute or models. It consumes third-party LLM capacity — marketing "LLM neutrality and support for self-hosted AI gateways, including air-gapped environments" — so it captures no model-layer economics and bears inference as COGS, visible in the $18.4 million rise in hosting costs. Its distinctive position is the regulated perimeter. | Mid-end and back-end equipment supplier to OSATs, IDMs and wafer-level-packaging subcontractors, with most of its business in advanced packaging for HPC, HBM and chiplets. |
| Products (share / barrier) |
|
|
|
| Long-horizon vote | +0.30 at weight 0.20 · swarm neutral Editorial prior, not backtested. | +0.06 at weight 0.20 · swarm neutral Editorial prior, not backtested. | +0.13 at weight 0.20 · swarm bearish Editorial prior, not backtested. |